Below are the most recent publications written about "Protozoan Proteins" by people in Profiles.
-
Zeleke AJ, Fola AA, Tollefson GA, Niar? K, Leonetti A, Taropawala O, Marglous J, Crudale R, Brhane BG, Assefa A, Kiyuka P, Parr JB, Hailu A, Tegegne MA, Bailey JA. High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia. PLoS Pathog. 2025 Dec; 21(12):e1013771.
-
Cummings BE, Stucke EM, Coulibaly D, Lawton JG, Sobota RS, Kone AK, Kane B, Guindo B, Tangara B, Sissoko M, Maiga F, Traore K, Diawara A, Traore A, Thera A, Dara A, Niangaly A, Daou M, Diarra I, Tolo Y, Sebastian S, Jain A, Nakajima R, Jasinskas A, Silzel EK, Shrestha B, Ouattara A, Munro JB, Laurens MB, Lyke KE, Tebben K, Bogale H, Plowe CV, Sissoko MS, Kouriba B, Takala-Harrison S, Felgner PL, Silva JC, Doumbo OK, Thera MA, Travassos MA. Plasmodium falciparum gene expression signatures and antibody profiling implicate the fikk, phist, and surf multigene families in severe malaria syndromes. J Infect. 2025 Dec; 91(6):106655.
-
Dos Santos NSA, de Almeida-J?nior CR, Ricci MF, Sanches RCO, Fernandes RS, Burle-Caldas GA, de Castro JT, Reis-Cunha JL, Bartholomeu DC, Meira ACM, Nascimento TG, Oliveira NFM, Gazzinelli RT, Machado FS, Teixeira SMR. RNA and protein immunization with Trypanosoma cruzi trans-sialidase containing SAPA repeats protects mice against infection and promotes a balanced inflammatory response. Front Cell Infect Microbiol. 2025; 15:1681807.
-
Martin AC, Sadler JM, Simkin A, Musonda M, Katowa B, Matoba J, Schue J, Simulundu E, Bailey JA, Moss WJ, Juliano JJ, Fola AA. Emergence and Rising Prevalence of Artemisinin Partial Resistance Marker Kelch13 P441L in a Low Malaria Transmission Setting in Southern Zambia. J Infect Dis. 2025 Oct 15; 232(4):918-922.
-
Watson OJ, Tran TN, Zupko RJ, Symons T, Thomson R, Visser T, Rumisha S, Dzianach PA, Hathaway N, Kim I, Juliano JJ, Bailey JA, Slater H, Okell L, Gething P, Ghani A, Boni MF, Parr JB, Cunningham J. Global risk of selection and spread of Plasmodium falciparum histidine-rich protein 2 and 3 gene deletions. Nat Med. 2025 Oct; 31(10):3372-3379.
-
G?mez-P?rez GP, Vidal M, Campo JJ, Moncunill G, Jimenez A, V?zquez-Santiago M, Ruiz-Olalla G, Sanz H, Ayestaran A, Angov E, Dutta S, Chitnis C, Chauhan V, James ER, Billingsley PF, Sim BKL, Kremsner PG, Hoffman SL, Lell B, Mordm?ller B, Doba?o C. IgM, IgG, and IgG Subclass Antibody Responses to Plasmodium falciparum Proteins in Na?ve, Malaria-Vaccinated and Semi-Immune Volunteers after Controlled Human Malaria Infection. Am J Trop Med Hyg. 2025 Dec 03; 113(6):1235-1248.
-
Juliano JJ, Meier-Scherling CPG, Wernsman Young N, Tollefson GA, Connelly SV, Parr JB, Conrad MD, Sadler JM, Hennelly CM, Assefa A, Okell L, Fola AA, Niar? K, Marglous J, Carey-Ewend K, Futila Kyong-Shin R, Gerdes Gyuricza I, Cuomo-Dannenburg G, Ruybal-Pes?ntez S, Watson OJ, Verity R, Bailey JA. Toward Setting Minimum and Optimal Data to Report for Malaria Molecular Surveillance with Targeted Sequencing: The "What" and "Why". Am J Trop Med Hyg. 2025 Dec 03; 113(6):1169-1177.
-
Okitwi M, Orena S, Tumwebaze PK, Katairo T, Taremwa Y, Byaruhanga O, Tukwasibwe S, Nsobya SL, Legac J, Bailey JA, Cooper RA, Conrad MD, Rosenthal PJ. Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019-2024. Nat Commun. 2025 Aug 09; 16(1):7353.
-
Rosado J, Fola AA, Cojean S, Sarrasin V, Copp?e R, Bailly J, Zaffaroulah R, Bouzayene A, Cic?ron L, Houz? L, Crudale R, Musset L, Thellier M, Pradines B, Clain J, Bailey JA, Houz? S. Assessment of ex vivo antimalarial drug efficacy in African Plasmodium falciparum parasite isolates, 2016-2023: a genotype-phenotype association study. EBioMedicine. 2025 Aug; 118:105835.
-
de Oliveira B, Goes WM, Nascimento FC, Carnielli JBT, Ferreira ER, de Carvalho AF, Dos Reis PVM, Pereira M, Ricotta TQN, Dos Santos LM, de Souza RP, Cargnelutti DE, Mottram JC, Teixeira SR, Fernandes AP, Gazzinelli RT. Characterization of a novel Leishmania antigen containing a repetitive domain and its potential use as a prophylactic and therapeutic vaccine. mSphere. 2025 May 27; 10(5):e0009725.